Page 52 - Merck Sharp News Today

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups.

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results published today in the New England Journal of Medicine.

Pharmac has reached provisional agreements with the markers of Keytruda and Tecentriq, following an increase to its budget in May.

The government is working towards expanding the scope of the human papillomavirus (HPV) immunization program to reduce the prevalence and death rate from ...

State-owned pharmaceutical firm PT Bio Farma established a technology transfer cooperation with an American pharmaceutical company, Merck Sharp & Dohme ...

The global smart insulin pens market is projected to grow positively owing to the rise in demand for smart insulin pens primarily due to an increase in diabetes mellitus prevalence due to genetic

President Director of state-owned pharmaceutical company PT Bio Farma Honesti Basyir stated that the Human Papillomavirus (HPV) vaccination program in 2023 ...

The global smart insulin pens market is projected to grow positively owing to the rise in demand for smart insulin pens primarily due to an increase in...

"The results of SERENA-2 support further development of camizestrant in ER-positive breast cancer."

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences, Inc. (Nasdaq: IMGO). On Nov. 21, 2022, Merck announced that it had entered into a definitive agreement to ...